Document Detail

Structural and biochemical properties of fibroblast growth factor 23.
MedLine Citation:
PMID:  16076373     Owner:  NLM     Status:  MEDLINE    
Fibroblast growth factor (FGF) 23 shares a fundamentally common structure with the members of the FGF family and has a unique sequence extension at the C-terminus. The molecular behavior of FGF23 as a systemic factor can be justified by the altered conformation of the beta-trefoil structure similar to that suspected in FGF19. On the other hand, the biological activity of FGF23 is quite distinct from those of other FGFs and requires the C-terminal unique extended structure. Two types of enzyme-linked immunosorbent assays (ELISA) have been developed to detect the intact mature form of FGF23 and its C-terminal portion. The former ELISA method enables the detection of rodent FGF23 and human FGF23. Studies on experimental animal models and laboratory examinations of physiologic and disordered conditions using these assays are contributing toward elucidating the physiology and pathophysiology of FGF23.
Takeyoshi Yamashita
Related Documents :
8051063 - Molecular determinants of bioactivity of the saccharomyces cerevisiae lipopeptide matin...
1688813 - Electron microscopic demonstration of a common structural motif in human complement fac...
18432873 - Autoimmune ovarian disease induced by immunization with zona pellucida (zp3) peptide.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy     Volume:  9     ISSN:  1744-9979     ISO Abbreviation:  Ther Apher Dial     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-03     Completed Date:  2005-12-13     Revised Date:  2006-11-07    
Medline Journal Info:
Nlm Unique ID:  101181252     Medline TA:  Ther Apher Dial     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  313-8     Citation Subset:  IM    
Pharmaceutical Research Laboratories, Pharmaceutical Division, Kirin Brewery Co., Ltd, Takasaki, Gunma, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amino Acid Sequence
Enzyme-Linked Immunosorbent Assay / methods*
Fibroblast Growth Factors / chemistry*
Protein Conformation
Protein Structure, Tertiary
Sequence Homology, Amino Acid*
Structure-Activity Relationship
Reg. No./Substance:
0/fibroblast growth factor 23; 62031-54-3/Fibroblast Growth Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fibroblast growth factor 23 and its receptors.
Next Document:  Post-translational modification of Fibroblast Growth Factor 23.